Effect of complementary food with small amounts of freshwater fish on whole blood n-3 fatty acids in Cambodian infants age 6-15 months

Prostaglandins Leukot Essent Fatty Acids. 2018 Aug:135:92-101. doi: 10.1016/j.plefa.2018.07.002. Epub 2018 Jul 9.

Abstract

The impact of freshwater fish consumption on the status of long-chain n-3 fatty acids (n-3 LCPUFA) in infants in landlocked, low-income populations is unknown. We used secondary data from a randomized, single-blinded, controlled trial to evaluate the impact of daily consumption of complementary food products with small amounts of freshwater fish on whole blood n-3 LCPUFA in Cambodian infants. Infants (n = 419), received daily, one of four food products for 9 months. Two products contained freshwater fish: WinFood (10% fish by dry weight) and WinFood-L (12% fish by dry weight), while two products were non-fish-based: corn-soy blends (CSB+ and CSB++). Whole blood fatty acids and breastfeeding status were assessed at baseline and endline of the intervention. The WinFood products contributed to an estimated maximum intake of 86.5 mg/day n-3 LCPUFA. There was no difference in whole blood n-3 LCPUFA among the four intervention groups or between the fish-based and the non-fish-based groups (p ≥ 0.142). At endline, 71% of the children were still breastfed. Interaction analyses indicated a lower ratio of n-6/n-3 PUFA in non-breastfed infants in the WinFood groups compared to the CSB groups (pinteraction = 0.026). Thus, a high intake of n-3 LCPUFA from breastmilk may have blurred a potential impact of small amounts of freshwater fish effect on n-3 LCPUFA status in Cambodian infants.

Keywords: Breastfeeding; Docosahexaenoic acid; Fish-based complementary food; n-3 LCPUFA status.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cambodia
  • Fatty Acids, Omega-3 / blood*
  • Female
  • Fishes*
  • Food, Fortified
  • Fresh Water
  • Humans
  • Infant
  • Infant Nutritional Physiological Phenomena
  • Lactation / blood
  • Male
  • Randomized Controlled Trials as Topic

Substances

  • Fatty Acids, Omega-3